Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Avecho.
RELATED STOCKHEAD STORIES
News
10 at 10: Investors are swarming around these ASX stocks this morning
Health & Biotech
ASX Health Stocks: Genetic Technologies jumps after EasyDNA acquisition ups cash receipts by $850k
Health & Biotech
ScoPo’s Powerplays: As focus turns to Delta variant, these ASX health stocks are profiting from COVID-19 testing
Explainers
CBD Oil: The ultimate investor’s guide to a potential $64 billion global market
News
Closing Bell: ASX retreats, led by 2pc drop in energy
Health & Biotech
ASX Health Stocks: Amplia begins Phase 2 trial for pancreatic cancer, while Avecho commences Phase 1 of cannabis gel
News
Weed Week: Cannabis trade shows and Europe imports medicinal marijuana
Health & Biotech
Weed Week: Major shifts in US legislation set to open the door for some ASX cannabis stocks
News
Market highlights and 5 ASX small caps to watch on Monday
Health & Biotech
Biotech Avecho just got the all-clear for human cannabis trials
Experts
ScoPo’s health powerplays: What to look for this earnings season
News
Rise and Shine: What you need to know before the ASX opens
Experts
ScoPo’s powerplays: Jazz Pharma’s $9.4b deal highlights pot plays
Health & Biotech
‘Pure biotech’ play Avecho is making a ‘terrifying’ move. Will it pay off?
Health & Biotech
Check Up: Rhythm Biosciences shares just keep on soaring
News
Winners Column: Here are the top 50 ASX small cap stocks for December
News
